Skip to main content

Hls Therapeutics Inc(HLS-T)
TSX

Today's Change
Real-Time Last Update
Volume

Hls Therapeutics Inc

10 Carlson Court
Suite 701
Etobicoke ON M9W6L2 CAN
P: 647-495-9000
F: 416-213-0045
https://www.hlstherapeutics.com

Sectors & Indices

Sector
Industry
Employees

Profile

HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada, the United States and the Rest of the world.

Key Executives

NameTitle
Gilbert GodinCEO/Director
Jason GrossVice President, Divisional
Tim HendricksonCFO
Ryan LennoxSecretary/Senior VP, Divisional
Hemanth VargheseSenior VP, Divisional
Sanjiv SharmaOther Executive Officer
Patricia PerryVice President, Divisional